News Janssen/AbbVie drug approved in graft-versus-host disease First use for Imbruvica outside blood cancer.
News Imbruvica granted fourth Breakthrough status The drug is also granted Orphan Drug Designation by the FDA.
News Better slashes staff in another digital health retreat Company will cut its headcount by 35%, as it waits for an FDA decision on its diabetes DTx.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
